Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 11, 2005

View Archived Issues

Clearance for phase I study of 1D09C3 in Germany

PainCeptor selects preclinical development lead candidates for key programs

Edison receives FARA grant to develop EPI-A0001 for Friedreich's ataxia

CTCE-9908 prevents human prostate cancer metastases in preclinical study

New phase I study for Heplisav HBV vaccine

Epitan reports results from European PMLE phase II study of EPT-1647

Weight loss seen in phase I study of oleoyl-estrone

Nicholas Piramal to acquire Avecia Pharmaceuticals

InterMune enrolls 600th patient in pivotal INSPIRE study

Approval for phase I study in Stem Cell Therapeutics' stroke program

European phase II trial studies Uvidem for melanoma

Aphton and sanofi pasteur to terminate Insegia agreements

European approval for Zeldox for manic or mixed episodes in bipolar disorder

Recent Ligand patent discloses novel androgen receptor modulators

Recent patents cover novel treatments for neurological disorders

Boehringer Ingelheim patents novel agents for treating inflammation

AVE-8062 reported to prevent proliferation of solid tumors in rats

KLF5 antagonists may play a role in the treatment of vascular diseases

SELENBP1 identified as candidate gene for schizophrenia using novel approach

New broad-spectrum antibiotics with a novel mechanism of action

Lentivirus-mediated gene therapy for sickle cell anemia and thalassemia to soon enter clinical trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...